Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Newamsterdam Pharma Co Nv (NAMS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,186,402 | 0.81 | Add 15.42% | 0.11 | $32.01 | $69,986,728 | SEC |
| 2025 Q4 | 1,894,226 | 0.71 | Add 25.88% | 0.15 | $35.08 | $66,449,448 | SEC |
| 2025 Q3 | 1,504,747 | 0.57 | Reduce 1.77% | <0.01 | $28.44 | $42,795,005 | SEC |
| 2025 Q2 | 1,531,874 | 0.43 | Add 178.79% | 0.28 | $18.11 | $27,742,238 | SEC |
| 2025 Q1 | 549,469 | 0.20 | Add 56.99% | 0.07 | $20.47 | $11,247,630 | SEC |
| 2024 Q4 | 350,005 | 0.16 | Buy | 0.16 | $25.70 | $8,995,129 | SEC |